Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent activity	RAD51 MYH6 PSMC6 ATP9B TOP6BL RAD54L2 DNAH1 IGHMBP2 MCM9 DDX25 DYNLRB1 DDX53 KIF2A DHX34 DNAH9 ATP2B2 KIF2C	5.98e-06	614	155	17	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal protein binding	CCDC170 EVL MYH6 HIP1 SPATA31A3 ANK3 MAP2 SPATA31A7 LRRK2 OBSCN CKAP5 GRIA2 NUF2 SPATA31A6 SPATA31A5 ADD3 TWF1 SPATA31A1 KIF2A AKAP1 CAP2 MRTFA KIF2C	1.35e-05	1099	155	23	GO:0008092
GeneOntologyMolecularFunction	nuclear import signal receptor activity	KPNA4 RANBP6 IPO11 KPNA3	1.54e-05	20	155	4	GO:0061608
GeneOntologyMolecularFunction	actin binding	EVL MYH6 HIP1 SPATA31A3 MAP2 SPATA31A7 LRRK2 SPATA31A6 SPATA31A5 ADD3 TWF1 SPATA31A1 CAP2 MRTFA	2.29e-05	479	155	14	GO:0003779
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate binding	HIP1 OBSCN SH3PXD2B ZFYVE26 VPS13B	3.46e-05	48	155	5	GO:0032266
GeneOntologyMolecularFunction	ATP hydrolysis activity	RAD51 PSMC6 ATP9B RAD54L2 IGHMBP2 MCM9 DDX25 DDX53 KIF2A DHX34 DNAH9 ATP2B2 KIF2C	4.15e-05	441	155	13	GO:0016887
GeneOntologyMolecularFunction	nucleocytoplasmic carrier activity	KPNA4 RANBP6 IPO11 KPNA3	1.06e-04	32	155	4	GO:0140142
GeneOntologyMolecularFunction	microtubule motor activity	DNAH1 DYNLRB1 KIF2A DNAH9 KIF2C	2.13e-04	70	155	5	GO:0003777
GeneOntologyMolecularFunction	helicase activity	RAD51 RAD54L2 IGHMBP2 MCM9 DDX25 DDX53 DHX34	2.38e-04	158	155	7	GO:0004386
GeneOntologyMolecularFunction	pyrophosphatase activity	RAD51 RAB31 RNGTT LRRK2 PSMC6 ATP9B RAD54L2 IGHMBP2 RHEBL1 MCM9 DDX25 DDX53 KIF2A DHX34 DNAH9 ATP2B2 KIF2C	2.87e-04	839	155	17	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	RAD51 RAB31 RNGTT LRRK2 PSMC6 ATP9B RAD54L2 IGHMBP2 RHEBL1 MCM9 DDX25 DDX53 KIF2A DHX34 DNAH9 ATP2B2 KIF2C	2.91e-04	840	155	17	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	RAD51 RAB31 RNGTT LRRK2 PSMC6 ATP9B RAD54L2 IGHMBP2 RHEBL1 MCM9 DDX25 DDX53 KIF2A DHX34 DNAH9 ATP2B2 KIF2C	2.91e-04	840	155	17	GO:0016818
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH6 DNAH1 DYNLRB1 KIF2A DNAH9 KIF2C	3.20e-04	118	155	6	GO:0003774
GeneOntologyMolecularFunction	calcium-dependent ATPase activity	MYH6 ATP2B2	3.56e-04	4	155	2	GO:0030899
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	RAD51 RAB31 LRRK2 PSMC6 ATP9B RAD54L2 IGHMBP2 RHEBL1 MCM9 DDX25 DDX53 KIF2A DHX34 DNAH9 ATP2B2 KIF2C	3.56e-04	775	155	16	GO:0017111
GeneOntologyMolecularFunction	phosphatidylinositol phosphate binding	HIP1 OBSCN TTPAL TWF1 SH3PXD2B ZFYVE26 VPS13B	9.44e-04	199	155	7	GO:1901981
GeneOntologyMolecularFunction	nuclear localization sequence binding	KPNA4 RANBP6 KPNA3	1.17e-03	27	155	3	GO:0008139
GeneOntologyBiologicalProcess	establishment or maintenance of microtubule cytoskeleton polarity	ANK3 CKAP5 KIF2C	4.04e-06	5	154	3	GO:0030951
GeneOntologyBiologicalProcess	protein depolymerization	EVL MAP2 SH3BP1 CKAP5 ADD3 TWF1 KIF2A KIF2C	1.28e-05	144	154	8	GO:0051261
GeneOntologyBiologicalProcess	establishment or maintenance of cytoskeleton polarity	ANK3 CKAP5 KIF2C	3.32e-05	9	154	3	GO:0030952
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	2.04e-06	12	153	4	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5	2.04e-06	12	153	4	IPR027970
Domain	EGF	SVEP1 MMRN1 NRXN3 CELSR3 HMCN1 VCAN LRP6	8.07e-05	126	153	7	PF00008
Domain	EGF_3	ADAM18 SVEP1 MMRN1 CNTNAP5 NRXN3 CELSR3 HMCN1 VCAN LRP6	1.41e-04	235	153	9	PS50026
Domain	VWF_A	INTS6L ITGAE SVEP1 INTS6 HMCN1 GABPB1	1.64e-04	99	153	6	IPR002035
Domain	P-loop_NTPase	RAD51 MYH6 RAB31 LRRK2 PSMC6 RAD54L2 DNAH1 NPHP3 ERAL1 IGHMBP2 RHEBL1 MCM9 DDX25 DDX53 KIF2A DHX34 DNAH9 KIF2C	2.05e-04	848	153	18	IPR027417
Domain	EGF-like_dom	ADAM18 SVEP1 MMRN1 CNTNAP5 NRXN3 CELSR3 HMCN1 VCAN LRP6	2.17e-04	249	153	9	IPR000742
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 MMRN1 NRXN3 CELSR3 HMCN1 VCAN	2.38e-04	106	153	6	IPR000152
Domain	EGF_1	ADAM18 SVEP1 MMRN1 CNTNAP5 NRXN3 CELSR3 HMCN1 VCAN LRP6	2.59e-04	255	153	9	PS00022
Domain	EGF_2	ADAM18 SVEP1 MMRN1 CNTNAP5 NRXN3 CELSR3 HMCN1 VCAN LRP6	3.43e-04	265	153	9	PS01186
Domain	Desmoglein	DSG1 DSG3	3.96e-04	4	153	2	IPR009123
Domain	SHR-BD	VPS13C VPS13B	3.96e-04	4	153	2	IPR009543
Domain	VPS13_C	VPS13C VPS13B	3.96e-04	4	153	2	PF16909
Domain	VPS13_C	VPS13C VPS13B	3.96e-04	4	153	2	IPR031645
Domain	SHR-BD	VPS13C VPS13B	3.96e-04	4	153	2	PF06650
Domain	VWFA	INTS6L ITGAE SVEP1 INTS6 HMCN1	5.68e-04	82	153	5	PS50234
Domain	VWA	INTS6L ITGAE SVEP1 INTS6 HMCN1	6.34e-04	84	153	5	SM00327
Domain	VWA_2	INTS6L INTS6	6.56e-04	5	153	2	PF13519
Domain	TLE_N	TLE5 TLE2	6.56e-04	5	153	2	PF03920
Domain	Autophagy-rel_C	VPS13C VPS13B	6.56e-04	5	153	2	IPR015412
Domain	Groucho/TLE_N	TLE5 TLE2	6.56e-04	5	153	2	IPR005617
Domain	ATG_C	VPS13C VPS13B	6.56e-04	5	153	2	PF09333
Domain	EGF	SVEP1 MMRN1 CNTNAP5 NRXN3 CELSR3 HMCN1 VCAN LRP6	7.22e-04	235	153	8	SM00181
Domain	Quino_amine_DH_bsu	FSTL5 LRRK2 FSTL4	7.40e-04	22	153	3	IPR011044
Domain	Sushi	SVEP1 VCAN CSMD1 SEZ6L	8.64e-04	52	153	4	PF00084
Domain	CCP	SVEP1 VCAN CSMD1 SEZ6L	9.96e-04	54	153	4	SM00032
Domain	SUSHI	SVEP1 VCAN CSMD1 SEZ6L	1.14e-03	56	153	4	PS50923
Domain	Sushi_SCR_CCP_dom	SVEP1 VCAN CSMD1 SEZ6L	1.22e-03	57	153	4	IPR000436
Domain	-	RAD51 RAB31 LRRK2 PSMC6 RAD54L2 DNAH1 NPHP3 ERAL1 IGHMBP2 RHEBL1 MCM9 DDX25 DDX53 DHX34 DNAH9	1.22e-03	746	153	15	3.40.50.300
Domain	Arm_3	KPNA4 KPNA3	1.36e-03	7	153	2	PF16186
Domain	Desmosomal_cadherin	DSG1 DSG3	1.36e-03	7	153	2	IPR009122
Domain	Importing_su_alpha	KPNA4 KPNA3	1.36e-03	7	153	2	IPR024931
Domain	IBB	KPNA4 KPNA3	1.36e-03	7	153	2	PF01749
Domain	Arm_3	KPNA4 KPNA3	1.36e-03	7	153	2	IPR032413
Domain	ASX_HYDROXYL	SVEP1 NRXN3 CELSR3 HMCN1 VCAN	1.39e-03	100	153	5	PS00010
Domain	EGF-like_CS	ADAM18 SVEP1 MMRN1 NRXN3 CELSR3 HMCN1 VCAN LRP6	1.42e-03	261	153	8	IPR013032
Domain	Chorein_N	VPS13C VPS13B	1.81e-03	8	153	2	PF12624
Domain	IBB	KPNA4 KPNA3	1.81e-03	8	153	2	PS51214
Domain	VPS13_N	VPS13C VPS13B	1.81e-03	8	153	2	IPR026854
Domain	INT_SG_DDX_CT_C	INTS6L INTS6	1.81e-03	8	153	2	PF15300
Domain	INT_SG_DDX_CT_C	INTS6L INTS6	1.81e-03	8	153	2	IPR029307
Domain	DEXDc	RAD54L2 IGHMBP2 DDX25 DDX53 DHX34	2.04e-03	109	153	5	SM00487
Domain	Helicase_ATP-bd	RAD54L2 IGHMBP2 DDX25 DDX53 DHX34	2.12e-03	110	153	5	IPR014001
Domain	Importin-a_IBB	KPNA4 KPNA3	2.31e-03	9	153	2	IPR002652
Domain	-	KPNA4 LRRK2 CKAP5 RANBP6 AP3B1 IPO11 KPNA3	2.39e-03	222	153	7	1.25.10.10
Domain	RNA-helicase_DEAD-box_CS	INTS6 DDX25 DDX53	2.46e-03	33	153	3	IPR000629
Domain	GPS	ADGRG1 CELSR3 ADGRF4	2.91e-03	35	153	3	PF01825
Domain	Kazal_2	FSTL5 FSTL4 SLCO4C1	3.16e-03	36	153	3	PF07648
Domain	GPS	ADGRG1 CELSR3 ADGRF4	3.16e-03	36	153	3	PS50221
Domain	-	INTS6L SVEP1 INTS6 HMCN1	3.19e-03	74	153	4	3.40.50.410
Domain	-	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 TGM4 LIFR HHLA2 PTPRB HMCN1 VCAN NECTIN4 HCFC1	3.21e-03	663	153	13	2.60.40.10
Domain	IGc2	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 HMCN1 NECTIN4	3.28e-03	235	153	7	SM00408
Domain	Ig_sub2	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 HMCN1 NECTIN4	3.28e-03	235	153	7	IPR003598
Domain	EGF_CA	SVEP1 MMRN1 CELSR3 HMCN1 VCAN	3.32e-03	122	153	5	SM00179
Domain	GPS	ADGRG1 CELSR3 ADGRF4	3.42e-03	37	153	3	IPR000203
Domain	GFP-like	SVEP1 HMCN1	3.49e-03	11	153	2	IPR023413
Domain	-	SVEP1 HMCN1	3.49e-03	11	153	2	2.40.155.10
Domain	EGF-like_Ca-bd_dom	SVEP1 MMRN1 CELSR3 HMCN1 VCAN	3.56e-03	124	153	5	IPR001881
Domain	LAM_G_DOMAIN	CNTNAP5 NRXN3 CELSR3	3.69e-03	38	153	3	PS50025
Domain	GDS_CDC24_CS	OBSCN ARHGEF3 DNMBP	3.97e-03	39	153	3	IPR001331
Domain	Laminin_G_2	CNTNAP5 NRXN3 CELSR3	4.27e-03	40	153	3	PF02210
Domain	Ig_I-set	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 HMCN1	4.81e-03	190	153	6	IPR013098
Domain	I-set	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 HMCN1	4.81e-03	190	153	6	PF07679
Domain	ig	CHL1 FSTL5 OBSCN FSTL4 HMCN1 NECTIN4	4.81e-03	190	153	6	PF00047
Domain	Immunoglobulin	CHL1 FSTL5 OBSCN FSTL4 HMCN1 NECTIN4	4.81e-03	190	153	6	IPR013151
Domain	PsdUridine_synth_cat_dom	DKC1 PUS7L	4.90e-03	13	153	2	IPR020103
Domain	Ig-like_fold	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 TGM4 LIFR HHLA2 PTPRB HMCN1 VCAN NECTIN4 HCFC1	5.41e-03	706	153	13	IPR013783
Domain	LamG	CNTNAP5 NRXN3 CELSR3	5.58e-03	44	153	3	SM00282
Domain	Dynein_heavy_chain_D4_dom	DNAH1 DNAH9	5.69e-03	14	153	2	IPR024317
Domain	VitD_rcpt	NR2C1 NR2C2	5.69e-03	14	153	2	IPR000324
Domain	Dynein_HC_stalk	DNAH1 DNAH9	5.69e-03	14	153	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH1 DNAH9	5.69e-03	14	153	2	IPR013602
Domain	DHC_N2	DNAH1 DNAH9	5.69e-03	14	153	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH1 DNAH9	5.69e-03	14	153	2	IPR011704
Domain	MT	DNAH1 DNAH9	5.69e-03	14	153	2	PF12777
Domain	AAA_8	DNAH1 DNAH9	5.69e-03	14	153	2	PF12780
Domain	AAA_5	DNAH1 DNAH9	5.69e-03	14	153	2	PF07728
Domain	DHC_fam	DNAH1 DNAH9	6.53e-03	15	153	2	IPR026983
Domain	BAR	SH3BP1 DNMBP	6.53e-03	15	153	2	SM00721
Domain	Dynein_heavy	DNAH1 DNAH9	6.53e-03	15	153	2	PF03028
Domain	BAR	SH3BP1 DNMBP	6.53e-03	15	153	2	PF03114
Domain	Dynein_heavy_dom	DNAH1 DNAH9	6.53e-03	15	153	2	IPR004273
Domain	AAA	RAD51 PSMC6 IGHMBP2 MCM9 DNAH9	6.68e-03	144	153	5	SM00382
Domain	AAA+_ATPase	RAD51 PSMC6 IGHMBP2 MCM9 DNAH9	6.68e-03	144	153	5	IPR003593
Domain	ARM-type_fold	KPNA4 HIP1 LRRK2 CKAP5 RANBP6 AP3B1 IPO11 KPNA3	6.91e-03	339	153	8	IPR016024
Domain	ARM-like	KPNA4 LRRK2 CKAP5 RANBP6 AP3B1 IPO11 KPNA3	6.92e-03	270	153	7	IPR011989
Domain	BAR_dom	SH3BP1 DNMBP	7.42e-03	16	153	2	IPR004148
Domain	CUB	NETO2 CSMD1 SEZ6L	7.54e-03	49	153	3	PF00431
Domain	-	SVEP1 CNTNAP5 NRXN3 CELSR3	7.75e-03	95	153	4	2.60.120.200
Domain	IG	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 HHLA2 HMCN1 VCAN NECTIN4	7.97e-03	421	153	9	SM00409
Domain	Ig_sub	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 HHLA2 HMCN1 VCAN NECTIN4	7.97e-03	421	153	9	IPR003599
Domain	7tm_2	ADGRG1 CELSR3 ADGRF4	7.97e-03	50	153	3	PF00002
Domain	KAZAL_2	FSTL5 FSTL4 SLCO4C1	7.97e-03	50	153	3	PS51465
Domain	G_PROTEIN_RECEP_F2_2	ADGRG1 CELSR3 ADGRF4	7.97e-03	50	153	3	PS00650
Domain	CUB	NETO2 CSMD1 SEZ6L	7.97e-03	50	153	3	SM00042
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NELFE EVL NR2C1 NR2C2 RNGTT CKAP5 PSMC6 EDC4 RAD54L2 EMSY GATAD2B PHF21A RCOR1 UBR5 CSNK2A2 RTRAF NFRKB DYNLRB1 ELF2 KIF2A HADHB QSER1 HCFC1 GABPB1 IPO11 KIF2C	4.53e-12	1103	156	26	34189442
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1	1.02e-11	6	156	5	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1	1.02e-11	6	156	5	25930072
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	RPL21 KPNA4 RAD51 MAP2 STK26 POLR2A GART RANBP6 PSMC6 EDC4 AP3B1 TWF1 TYMS TLE5 CSNK2A2 ASL RTRAF PAFAH1B3 NFRKB DYNLRB1 DNMBP HCFC1 CAP2 IPO11 KPNA3	8.26e-09	1455	156	25	22863883
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RPL21 NELFE NR2C1 DSG1 TCOF1 TBC1D5 POLR2A GART CKAP5 EDC4 EMSY PHF21A ADD3 TWF1 CCDC43 SMG7 DKC1 ELF2 AKAP1 HCFC1	8.39e-09	934	156	20	33916271
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ANK3 TUT7 OBSCN PHTF2 AP3B1 TGM4 SH3PXD2B RCOR1 NPHP3 ERAL1 CSNK2A2 VCAN NFRKB NFYC KIF2A QSER1 ARHGEF3 VPS13B MRTFA KIF2C KPNA3	1.95e-08	1084	156	21	11544199
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	RPL21 NELFE POLR2A RANBP6 AP3B1 GATAD2B NSD3 CSNK2A2 NFRKB DKC1 KIF2A CAP2 IPO11 KIF2C KPNA3	2.07e-08	533	156	15	30554943
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	NELFE DSG1 TCOF1 POLR2A CKAP5 PHF21A UBR5 CSNK2A2 RTRAF NFRKB HCFC1 IPO11 KPNA3	2.67e-08	390	156	13	17643375
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NELFE ANK3 TCOF1 POLR2A EDC4 AP3B1 EMSY ADD3 NSD3 CCDC43 SH3PXD2B SMG7 NFRKB QSER1 HCFC1	3.05e-08	549	156	15	38280479
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	NR2C1 POLR2A MUC19 EMSY GATAD2B PHF21A RCOR1 NFRKB PSMC3IP DKC1 ELF2 HCFC1	4.86e-08	339	156	12	30415952
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	KPNA4 HIP1 RNGTT POLR2A CKAP5 ADGRG1 PSMC6 EDC4 AP3B1 TTF1 EMSY GATAD2B NSD3 TWF1 INTS6 CSNK2A2 IGHMBP2 RTRAF NFRKB KIF2A DNMBP AKAP1 KIF2C KPNA3	6.25e-08	1497	156	24	31527615
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31A6 SPATA31A5 SPATA31A1	6.75e-08	24	156	5	32212159
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ANK3 TCOF1 TBC1D5 SH3BP1 CKAP5 GRIA2 EDC4 EMSY GATAD2B TWF1 SH3PXD2B RCOR1 CNTNAP5 UBR5 CSNK2A2 KIF2A QSER1 CAP2 KIF2C	7.35e-08	963	156	19	28671696
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL21 NR2C2 TCOF1 POLR2A CKAP5 TTF1 EMSY GATAD2B PHF21A NSD3 RYBP INTS6 RCOR1 NFRKB TMEM209 DKC1 ZNF740 ELF2 HADHB QSER1 HCFC1 KIF2C	8.61e-08	1294	156	22	30804502
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	RPL21 STK26 POLR2A GART CKAP5 PSMC6 EDC4 AP3B1 ADD3 ERAL1 RTRAF DKC1 KIF2A HADHB IPO11	2.12e-07	638	156	15	33239621
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	KPNA4 TCOF1 VPS13C POLR2A GART EDC4 TWF1 TYMS CCDC43 RDH11 UBR5 ERAL1 HADHB AKAP1 MRTFA KIF2C	3.23e-07	754	156	16	35906200
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NELFE NR2C2 EMSY PHF21A RCOR1 TLE5 NFRKB ELF2 QSER1 HCFC1	4.08e-07	268	156	10	33640491
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	KPNA4 ANK3 MAP2 POLR2A OBSCN PSMC6 SPATA31A6 PTPRB IGHMBP2 KIF2A HCFC1 IPO11 KIF2C	4.32e-07	497	156	13	36774506
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RPL21 NR2C1 NR2C2 TCOF1 GART PSMC6 AP3B1 TTF1 EMSY TYMS CSNK2A2 RTRAF PAFAH1B3 NFRKB DKC1 KIF2A HADHB HCFC1 MAD2L1 IPO11 KIF2C	5.03e-07	1318	156	21	30463901
Pubmed	The functional interactome landscape of the human histone deacetylase family.	KPNA4 POLR2A EMSY GATAD2B PHF21A ADD3 RCOR1 UBR5 DKC1 KPNA3	8.10e-07	289	156	10	23752268
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NELFE NR2C1 NR2C2 TBC1D5 RAD54L2 EMSY GATAD2B PHF21A ADD3 NFRKB ELF2 HCFC1	8.67e-07	444	156	12	34795231
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	RPL21 KPNA4 DSG1 TCOF1 FSTL4 PSMC6 EDC4 AP3B1 GATAD2B SMG7 ERAL1 CSNK2A2 RTRAF DYNLRB1 HADHB ENO3 HCFC1 MAD2L1 KPNA3	1.12e-06	1153	156	19	29845934
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	MUC19 TTF1 EMSY PHF21A ELF2 DNAH9 HCFC1	1.47e-06	123	156	7	26912792
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	RPL21 VPS13C TBC1D5 TUT7 CKAP5 EMSY CCDC43 SH3PXD2B SMG7 UBR5 CEP250 TMEM209 DKC1 DYNLRB1 DNMBP CNOT4	1.62e-06	853	156	16	28718761
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	VPS13C TBC1D5 CKAP5 AP3B1 TWF1 CCDC43 SH3PXD2B SLC30A5 UBR5 TMEM209 AKAP1 HCFC1 VPS13B	1.90e-06	568	156	13	37774976
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	KPNA4 TCOF1 POLR2A CKAP5 NRXN3 UBR5 CSNK2A2 VCAN KPNA3	2.18e-06	251	156	9	28077445
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	KPNA4 NELFE RAD51 PSMC6 IRF2 EDC4 EMSY INTS6 SMG7 SLC15A2 UBR5 MCM9 MCUR1 NFRKB PSMC3IP DKC1 ELF2 ENO3 GABPB1 KPNA3	2.25e-06	1327	156	20	32694731
Pubmed	Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells.	NR2C1 NR2C2 RCOR1 HCFC1	3.23e-06	23	156	4	21670149
Pubmed	Interaction network of human early embryonic transcription factors.	NR2C1 NR2C2 RAD54L2 EMSY PHF21A RCOR1 TLE5 NFRKB ELF2 QSER1	4.59e-06	351	156	10	38297188
Pubmed	An actin-regulated importin α/β-dependent extended bipartite NLS directs nuclear import of MRTF-A.	KPNA4 MRTFA KPNA3	4.88e-06	8	156	3	20818336
Pubmed	TTBK2 with EB1/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation.	CKAP5 KIF2A KIF2C	4.88e-06	8	156	3	26323690
Pubmed	Human transcription factor protein interaction networks.	NR2C1 NR2C2 PSMC6 EDC4 RAD54L2 EMSY GATAD2B PHF21A RYBP RCOR1 SMG7 TLE5 CSNK2A2 NFRKB NFYC LRP6 ELF2 HADHB QSER1 HCFC1	6.76e-06	1429	156	20	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RPL21 EVL MYH6 ANK3 MAP2 STK26 CKAP5 GRIA2 EDC4 AP3B1 ADD3 TWF1 CSNK2A2 LGI3 RTRAF VCAN KIF2A HADHB ATP2B2 KPNA3	6.90e-06	1431	156	20	37142655
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	HIP1 RANBP6 PSMC6 IRF2 EDC4 TWF1 LIFR RDH11 UBR5 ERAL1 CSNK2A2 RTRAF TMEM209 DKC1 DYNLRB1 ZNF740 HADHB HCFC1 IPO11 KPNA3	7.57e-06	1440	156	20	30833792
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	RAD54L2 AP3B1 EMSY MCM9 KIF2A ZNF518B HCFC1 KIF2C	7.84e-06	222	156	8	37071664
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	RPL21 NR2C2 POLR2A CKAP5 IRF2 TTF1 EMSY GATAD2B PHF21A UBR5 ERAL1 NFYC QSER1 HCFC1 KIF2C	7.99e-06	857	156	15	25609649
Pubmed	Proteomic and Interactome Approaches Reveal PAK4, PHB-2, and 14-3-3η as Targets of Overactivated Cdc42 in Cellular Responses to Genomic Instability.	TRAF7 DSG1 GART PSMC6 EDC4 TYMS HADHB DNMBP	8.64e-06	225	156	8	31478661
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	RPL21 KPNA4 RNGTT TCOF1 POLR2A GART RANBP6 PSMC6 GATAD2B RCOR1 UBR5 ERAL1 CSNK2A2 RTRAF DKC1 KIF2A HADHB HCFC1 KPNA3	9.26e-06	1335	156	19	29229926
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	TCOF1 GART CKAP5 PSMC6 EDC4 AP3B1 TWF1 CSNK2A2 ASL HADHB ENO3 HCFC1 MAD2L1	1.04e-05	665	156	13	30457570
Pubmed	METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis.	RPL21 CKAP5 RANBP6 PSMC6 ITGAE CELSR3 UBR5 RTRAF	1.05e-05	231	156	8	36597993
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NELFE EVL TCOF1 POLR2A CKAP5 EMSY GATAD2B CSNK2A2 NFRKB DKC1 ELF2 DNMBP AKAP1 MRTFA	1.13e-05	774	156	14	15302935
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TRAF7 TCOF1 POLR2A GATAD2B PHF21A NSD3 INTS6 RCOR1 SMG7 UBR5 CSNK2A2 NFRKB ZNF740 CSMD1 DHX34 SEZ6L KPNA3	1.19e-05	1116	156	17	31753913
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	KPNA4 NR2C2 GATAD2B PHF21A CSNK2A2 NFRKB NFYC ZNF518B HADHB KPNA3	1.37e-05	398	156	10	35016035
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	RPL21 RNGTT DSG1 STK26 POLR2A GART PSMC6 TYMS UBR5 ERAL1 RTRAF TMEM209 DKC1 DYNLRB1 HADHB HCFC1 MAD2L1 KPNA3	1.49e-05	1257	156	18	37317656
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	POLR2A GATAD2B PHF21A INTS6 RCOR1 NFRKB HCFC1	1.62e-05	177	156	7	26206133
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	KPNA4 NR2C2 RNGTT TCOF1 TTF1 RCOR1 HADHB QSER1 DNMBP HCFC1	1.77e-05	410	156	10	26949251
Pubmed	Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.	AP3B1 CSMD1 SEZ6L	1.89e-05	12	156	3	21901158
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RPL21 KPNA4 NELFE RAD51 DSG1 TCOF1 POLR2A GART PSMC6 NUF2 AP3B1 UBR5 TLE5 CSNK2A2 CD40 MAD2L1 IPO11 KPNA3	1.98e-05	1284	156	18	17353931
Pubmed	The nuclear localization sequence of the epigenetic factor RYBP binds to human importin α3.	KPNA4 RYBP	2.00e-05	2	156	2	33945888
Pubmed	Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.	CLDN6 CLDN9	2.00e-05	2	156	2	17804490
Pubmed	Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.	DSG1 DSG3	2.00e-05	2	156	2	28620161
Pubmed	TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.	NR2C2 TBC1D25	2.00e-05	2	156	2	32210723
Pubmed	Characterization of the nucleolar gene product, treacle, in Treacher Collins syndrome.	TCOF1 CSNK2A2	2.00e-05	2	156	2	10982400
Pubmed	Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.	NR2C1 NR2C2	2.00e-05	2	156	2	22042865
Pubmed	A bidirectional regulation between the TR2/TR4 orphan receptors (TR2/TR4) and the ciliary neurotrophic factor (CNTF) signaling pathway.	NR2C1 NR2C2	2.00e-05	2	156	2	9694834
Pubmed	Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation.	DSG1 DSG3	2.00e-05	2	156	2	12485422
Pubmed	Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4.	NR2C1 NR2C2	2.00e-05	2	156	2	17431400
Pubmed	Cellular Importin-α3 Expression Dynamics in the Lung Regulate Antiviral Response Pathways against Influenza A Virus Infection.	KPNA4 KPNA3	2.00e-05	2	156	2	32320654
Pubmed	Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion.	DSG1 DSG3	2.00e-05	2	156	2	12164920
Pubmed	Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion.	DSG1 DSG3	2.00e-05	2	156	2	1720352
Pubmed	A novel nuclear receptor heterodimerization pathway mediated by orphan receptors TR2 and TR4.	NR2C1 NR2C2	2.00e-05	2	156	2	9737983
Pubmed	Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.	CLDN6 CLDN9	2.00e-05	2	156	2	23864633
Pubmed	Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.	DSG1 DSG3	2.00e-05	2	156	2	17640963
Pubmed	Genetic loss of importin α4 causes abnormal sperm morphology and impacts on male fertility in mouse.	KPNA4 KPNA3	2.00e-05	2	156	2	33058343
Pubmed	Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris.	DSG1 DSG3	2.00e-05	2	156	2	21602032
Pubmed	Roles of testicular orphan nuclear receptors 2 and 4 in early embryonic development and embryonic stem cells.	NR2C1 NR2C2	2.00e-05	2	156	2	19131575
Pubmed	Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.	DSG1 DSG3	2.00e-05	2	156	2	11120754
Pubmed	The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.	DSG1 DSG3	2.00e-05	2	156	2	23297065
Pubmed	Efficient mitosis in human cells lacking poleward microtubule flux.	KIF2A KIF2C	2.00e-05	2	156	2	16243029
Pubmed	Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily.	NR2C1 NR2C2	2.00e-05	2	156	2	12361719
Pubmed	The human genes for desmogleins (DSG1 and DSG3) are located in a small region on chromosome 18q12.	DSG1 DSG3	2.00e-05	2	156	2	8034325
Pubmed	Dsg1 and Dsg3 Composition of Desmosomes Across Human Epidermis and Alterations in Pemphigus Vulgaris Patient Skin.	DSG1 DSG3	2.00e-05	2	156	2	35711465
Pubmed	A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder.	CNTNAP5 CSMD1	2.00e-05	2	156	2	30722798
Pubmed	Detailed haplotype-tagging study of germline variation of MUC19 in inflammatory bowel disease.	LRRK2 MUC19	2.00e-05	2	156	2	19714762
Pubmed	Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB.	KPNA4 KPNA3	2.00e-05	2	156	2	28179530
Pubmed	Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.	LRRK2 LRP6	2.00e-05	2	156	2	27013965
Pubmed	MCAK-independent functions of ch-Tog/XMAP215 in microtubule plus-end dynamics.	CKAP5 KIF2C	2.00e-05	2	156	2	18809577
Pubmed	Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.	DSG1 DSG3	2.00e-05	2	156	2	9405290
Pubmed	Biochemical analysis of the human EVL domains in homologous recombination.	RAD51 EVL	2.00e-05	2	156	2	19725871
Pubmed	The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK.	KIF2A KIF2C	2.00e-05	2	156	2	15302853
Pubmed	Defining the membrane proteome of NK cells.	RPL21 EVL CKAP5 PSMC6 TTPAL NUF2 EDC4 AP3B1 UBR5 IGHMBP2 PAFAH1B3 DYNLRB1 KIF2A AKAP1 DHX34 HCFC1 KIF2C	2.13e-05	1168	156	17	19946888
Pubmed	Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.	TRAF7 HIP1 TUT7 PHTF2 TLE2 MCUR1 ZFYVE26 HADHB CSMD1 DHX34 MGAT5B ENO3 ATP2B2 KIF2C	2.50e-05	832	156	14	36724073
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	ANK3 VPS13C CKAP5 PHF21A NRXN3 ATP2B2	2.56e-05	128	156	6	30995482
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KPNA4 TCTN3 RNGTT ANK3 PSMC6 TBC1D25 NUF2 AP3B1 PHF21A RCOR1 NPHP3 RDH11 DYNLRB1 QSER1 ATP2B2 IPO11 KIF2C KPNA3	2.87e-05	1321	156	18	27173435
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	RPL21 CKAP5 SH3PXD2B RCOR1 NFRKB AKAP1 HCFC1 MRTFA	2.96e-05	267	156	8	33417871
Pubmed	Essential role of Rac1 and Rac3 GTPases in neuronal development.	MAP2 GRIA2 SLC30A5	3.11e-05	14	156	3	19126596
Pubmed	A protein interaction landscape of breast cancer.	KPNA4 EVL ANK3 TCOF1 POLR2A TWF1 UBR5 CSNK2A2 MCM9 DKC1 HADHB KPNA3	3.15e-05	634	156	12	34591612
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	POLR2A GART CKAP5 PSMC6 GATAD2B RCOR1 RDH11 UBR5 TMEM209 MAD2L1 KPNA3	3.17e-05	534	156	11	35032548
Pubmed	Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.	HIP1 TBC1D5 STK26 PSMC6 RBKS GATAD2B PHF21A MAB21L3 TLE5 CSNK2A2 ASL RTRAF PAFAH1B3 CD40 KIF2A ARHGEF3 IQUB MAD2L1 PUS7L	3.72e-05	1477	156	19	31515488
Pubmed	Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.	KPNA4 GART TYMS MCM9 TMEM209 PSMC3IP HADHB ENO3 CNOT4	3.79e-05	359	156	9	35559673
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	RAD51 NR2C1 NR2C2 RNGTT RAD54L2 EMSY UBR5 KIF2A MAD2L1 KIF2C	4.11e-05	453	156	10	29656893
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EVL ANK3 MAP2 VPS13C TBC1D5 OBSCN ADGRG1 ATP9B TTF1 DNAH1 INTS6 PTPRB SMG7 RDH11 TLE5 QSER1 CSMD1 VPS13B CAP2	4.14e-05	1489	156	19	28611215
Pubmed	Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.	CCDC170 CKAP5 NFYC CSMD1	4.60e-05	44	156	4	20200978
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	RAD51 POLR2A CKAP5 ADD3 NSD3 INTS6 RCOR1 MAD2L1 KPNA3	4.79e-05	370	156	9	22922362
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	NUF2 TTF1 RCOR1 UBR5 NFRKB DKC1 KIF2A	4.82e-05	210	156	7	16565220
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	TCTN3 DSG1 MAP2 VPS13C OBSCN NPHP3 VCAN HADHB ENO3 MAD2L1 KIF2C	5.19e-05	564	156	11	21565611
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	POLR2A EMSY GATAD2B RYBP QSER1 HCFC1	5.35e-05	146	156	6	23892456
Pubmed	High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.	KPNA4 TCOF1 TUT7 GART AP3B1 GATAD2B RTRAF DKC1 KIF2A HCFC1	5.49e-05	469	156	10	37314180
Pubmed	An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.	GATAD2B NFRKB NFYC HCFC1 KPNA3	5.80e-05	91	156	5	20362542
Pubmed	Differential and bi-directional regulation between TR2/TR4 orphan nuclear receptors and a specific ligand mediated-peroxisome proliferator-activated receptor alpha in human HaCaT keratinocytes.	NR2C1 NR2C2	5.98e-05	3	156	2	12615366
Interaction	CHD8 interactions	KPNA4 NR2C2 AP3B1 PHF21A NSD3 RCOR1 SMG7 DKC1 HCFC1 MAD2L1 KPNA3	3.05e-07	193	155	11	int:CHD8
Interaction	CEBPA interactions	NELFE EVL NR2C1 NR2C2 RNGTT POLR2A CKAP5 PSMC6 EDC4 RAD54L2 EMSY GATAD2B PHF21A RCOR1 UBR5 CSNK2A2 RTRAF NFRKB DYNLRB1 ELF2 KIF2A HADHB QSER1 HCFC1 GABPB1 IPO11 KIF2C	9.16e-07	1245	155	27	int:CEBPA
Interaction	NUP43 interactions	RAD51 NR2C1 NR2C2 DSG1 MUC19 RAD54L2 TTF1 EMSY PHF21A NSD3 UBR5 CEP250 NFRKB DKC1 ELF2 KIF2A DNAH9 HCFC1	1.58e-06	625	155	18	int:NUP43
Interaction	KLF3 interactions	NR2C1 NR2C2 EMSY GATAD2B PHF21A RYBP RCOR1 TLE5 NFRKB ELF2 QSER1	1.58e-06	228	155	11	int:KLF3
Interaction	EGR2 interactions	NR2C1 NR2C2 RAD54L2 EMSY PHF21A TLE5 NFRKB QSER1 HCFC1	7.19e-06	171	155	9	int:EGR2
Interaction	ZMYND8 interactions	NR2C2 EMSY GATAD2B PHF21A INTS6 RCOR1 CSNK2A2 DNAH9 KPNA3	1.75e-05	191	155	9	int:ZMYND8
Interaction	NAA40 interactions	RPL21 NELFE NR2C1 NR2C2 DSG1 TCOF1 TBC1D5 POLR2A GART CKAP5 EDC4 EMSY PHF21A ADD3 TWF1 CCDC43 SMG7 DKC1 ELF2 AKAP1 HCFC1	1.99e-05	978	155	21	int:NAA40
Interaction	PHF12 interactions	EMSY GATAD2B PHF21A RCOR1 NFYC ELF2 QSER1	2.28e-05	110	155	7	int:PHF12
Interaction	DVL2 interactions	NR2C2 HIP1 VPS13C LRRK2 PSMC6 ATP9B PHF21A LIFR RCOR1 HMCN1 TLE5 CSNK2A2 KIF2A HADHB KIF2C	2.70e-05	557	155	15	int:DVL2
Interaction	POLR2K interactions	NELFE INTS6L NR2C2 POLR2A RYBP INTS6 CSNK2A2 KPNA3	2.70e-05	155	155	8	int:POLR2K
Interaction	FEV interactions	NR2C1 NR2C2 RAD54L2 EMSY PHF21A RYBP TLE5 NFRKB QSER1	2.83e-05	203	155	9	int:FEV
Interaction	PML interactions	RPL21 KPNA4 NELFE RAD51 TCTN3 NR2C1 NR2C2 TBC1D5 PSMC6 RAD54L2 EMSY GATAD2B PHF21A ADD3 INTS6 UBR5 NFRKB ELF2 HADHB HCFC1	3.28e-05	933	155	20	int:PML
Interaction	CTDP1 interactions	RNGTT POLR2A NUF2 INTS6 UBR5 ERAL1 CSNK2A2 MAD2L1 IPO11	3.30e-05	207	155	9	int:CTDP1
Interaction	SLX4 interactions	DSG1 POLR2A GART RAD54L2 AP3B1 EMSY GATAD2B UBR5 MCM9 KIF2A ZNF518B HCFC1 MAD2L1 KIF2C KPNA3	3.66e-05	572	155	15	int:SLX4
Interaction	NR2C1 interactions	NR2C1 NR2C2 RCOR1 NFYC ELF2 HCFC1	4.66e-05	84	155	6	int:NR2C1
Interaction	STIP1 interactions	RPL21 NR2C2 STK26 POLR2A GART LRRK2 CKAP5 PSMC6 EDC4 AP3B1 ADD3 ERAL1 CSNK2A2 RTRAF DKC1 KIF2A HADHB AKAP1 ENO3 IPO11	9.29e-05	1006	155	20	int:STIP1
Interaction	PYHIN1 interactions	KPNA4 NR2C2 TCOF1 POLR2A CKAP5 GATAD2B NRXN3 UBR5 CSNK2A2 VCAN KPNA3	1.06e-04	358	155	11	int:PYHIN1
Interaction	DYNLT1 interactions	TCTN3 NR2C2 EMSY ADD3 NFRKB DYNLRB1 ELF2 KIF2A HCFC1	1.07e-04	241	155	9	int:DYNLT1
Interaction	RAD51 interactions	RAD51 EVL DSG1 RAD54L2 PHF21A NSD3 RCOR1 MCM9 PSMC3IP	1.07e-04	241	155	9	int:RAD51
Interaction	DCTN1 interactions	MAP2 TBC1D5 STK26 CKAP5 NUF2 TWF1 SH3PXD2B RCOR1 AATK DYNLRB1 KIF2A ENO3 KIF2C	1.26e-04	497	155	13	int:DCTN1
Interaction	ASF1A interactions	NR2C2 POLR2A EMSY GATAD2B NSD3 NFRKB ELF2 QSER1 HCFC1	1.36e-04	249	155	9	int:ASF1A
Interaction	POLR2B interactions	KPNA4 NELFE INTS6L NR2C2 RNGTT TCOF1 POLR2A INTS6 NRXN3 AKAP1 KPNA3	1.44e-04	371	155	11	int:POLR2B
Cytoband	12q12	LRRK2 MUC19 TWF1 PUS7L	2.04e-05	47	156	4	12q12
Cytoband	Ensembl 112 genes in cytogenetic band chr12q12	LRRK2 MUC19 TWF1 PUS7L	6.54e-05	63	156	4	chr12q12
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	3.17e-04	8	156	2	chr9q12
GeneFamily	Armadillo repeat containing\|Importins	KPNA4 IPO11 KPNA3	1.22e-04	18	99	3	596
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 ADAMTSL1 FSTL5 OBSCN FSTL4 HMCN1	2.57e-04	161	99	6	593
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	SVEP1 VCAN CSMD1 SEZ6L	2.67e-04	57	99	4	1179
GeneFamily	Desmosomal cadherins	DSG1 DSG3	6.12e-04	7	99	2	1188
Coexpression	JOHNSTONE_PARVB_TARGETS_3_DN	NR2C1 PHTF2 PSMC6 ATP9B NUF2 ITGAE NSD3 TYMS RYBP CCDC43 SLC30A5 TMEM209 DKC1 KIF2A QSER1 MAD2L1 KIF2C KPNA3	3.56e-06	877	152	18	M2241
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	RAD51 MAP2 TCOF1 POLR2A CKAP5 NUF2 TYMS ERAL1 VCAN PAFAH1B3 PSMC3IP DKC1 MAD2L1 KIF2C	7.37e-06	578	152	14	M2368
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	CHL1 ANK3 MAP2 FSTL4 MUC19 NRXN3 CELSR3 TLE2 ARHGEF3 CSMD1 AKAP1 ATP2B2 SEZ6L	8.48e-06	506	152	13	M39067
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	RAD51 MAP2 TCOF1 POLR2A CKAP5 NUF2 TYMS ERAL1 VCAN PAFAH1B3 PSMC3IP DKC1 MAD2L1 KIF2C	1.06e-05	597	152	14	MM1309
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL	NELFE TRAF7 TCOF1 GART CKAP5 NUF2 EDC4 AP3B1 TTF1 TYMS RCOR1 ERAL1 ASL PAFAH1B3 MCUR1 TMEM209 PSMC3IP DKC1 HCFC1 MAD2L1 KIF2C KPNA3	1.31e-05	1363	152	22	M45782
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	RAD51 GART CKAP5 NUF2 TTF1 NSD3 TYMS CCDC43 RCOR1 MAB21L3 SLC30A5 UBR5 NETO2 MCUR1 NFYC PSMC3IP DKC1 KIF2A MAD2L1 GABPB1 KIF2C	1.86e-05	1290	152	21	M80
Coexpression	GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP	RAD51 NUF2 TYMS RHEBL1 ENO3 HCFC1 MAD2L1 KIF2C	2.21e-05	199	152	8	M8277
Coexpression	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	TBC1D5 GART AP3B1 CLDN6 EMSY MMRN1 GUCY1B1 KPNA3	2.21e-05	199	152	8	M5799
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP	NR2C1 RNGTT ANK3 TBC1D5 GART TTF1 TWF1 CSNK2A2 PSMC3IP ELF2 AKAP1 MRTFA	2.25e-05	475	152	12	M40979
Coexpression	NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR	ADAMTSL1 SVEP1 MMRN1 HMCN1 HCFC1	2.39e-05	59	152	5	M47989
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	RAB31 RNGTT CKAP5 AP3B1 PHF21A RYBP RCOR1 UBR5 NFYC KIF2A DNMBP CNOT4 VPS13B CAP2 MRTFA KPNA3	3.98e-05	856	152	16	M4500
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	RAD51 TCOF1 PHTF2 NUF2 TOP6BL TYMS NRXN3 RHEBL1 PSMC3IP KIF2A MAD2L1 GABPB1 KIF2C	4.07e-05	588	152	13	M38992
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	TCOF1 POLR2A TLE5 CD40 KIF2A DHX34 CNOT4 GABPB1	4.37e-05	219	152	8	M41199
Coexpression	FISCHER_DREAM_TARGETS	RAD51 TCOF1 GART CKAP5 PHTF2 NUF2 TTF1 PAFAH1B3 TMEM209 PSMC3IP KIF2A HCFC1 MAD2L1 GABPB1 IPO11 KIF2C KPNA3	4.97e-05	969	152	17	M149
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	VPS13C TBC1D5 PHF21A NRXN3 ELF2 ARHGEF3 VPS13B	6.04e-05	169	152	7	M39230
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	KPNA4 RNGTT GART CKAP5 TTPAL NUF2 TWF1 CELSR3 VCAN ADGRF4 KIF2A QSER1 MAD2L1 GABPB1	8.27e-05	721	152	14	M10237
Coexpression	DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	STK26 ITGAE PHF21A UBR5 VCAN PAFAH1B3 DKC1 KIF2C	8.80e-05	242	152	8	M34034
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	RNGTT CKAP5 PHF21A RCOR1 UBR5 NFYC KIF2A DNMBP CNOT4 CAP2 KPNA3	9.12e-05	466	152	11	M13522
Coexpression	PATIL_LIVER_CANCER	NELFE TCOF1 TBC1D5 NUF2 PHF21A TYMS SH3PXD2B SMG7 UBR5 PAFAH1B3 HCFC1 MAD2L1 CAP2	1.30e-04	660	152	13	M1195
Coexpression	GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN	PHTF2 RAD54L2 NSD3 PAFAH1B3 PSMC3IP ELF2 VPS13B	1.52e-04	196	152	7	M8143
Coexpression	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	TYMS CELSR3 NETO2 PAFAH1B3 MAD2L1 KIF2C	1.71e-04	140	152	6	M15664
Coexpression	GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP	HIP1 INTS6 CD40 DKC1 DYNLRB1 ARHGEF3 KIF2C	1.72e-04	200	152	7	M8483
Coexpression	GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN	STK26 TUT7 LRRK2 ADGRG1 IRF2 CD40 ZFYVE26	1.72e-04	200	152	7	M3861
Coexpression	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN	NELFE RAD51 GART CKAP5 TYMS MCUR1 KIF2C	1.72e-04	200	152	7	M5300
Coexpression	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP	NELFE RAD51 TYMS PSMC3IP DKC1 PUS7L KIF2C	1.72e-04	200	152	7	M6553
Coexpression	GSE3982_NKCELL_VS_TH2_DN	RAD51 MYH6 EMSY TYMS INTS6 RTRAF KIF2C	1.72e-04	200	152	7	M5598
Coexpression	GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP	EDC4 RDH11 MCM9 QSER1 ARHGEF3 ENO3 IPO11	1.72e-04	200	152	7	M5602
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	TCTN3 NR2C1 HIP1 MAP2 TCOF1 GART PHF21A TWF1 TYMS CCDC43 TMEM209 NFYC HCFC1 KPNA3	1.78e-04	776	152	14	M1107
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	CHL1 ADAMTSL1 ANK3 FSTL5 GRIA2 GATAD2B PHF21A LIFR NRXN3 CELSR3 SLC15A2 LGI3 VCAN NECTIN4 KIF2A ZNF518B DNMBP VPS13B	2.14e-05	818	151	18	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000	CHL1 RAD51 ADAMTSL1 ANK3 LRRK2 PHTF2 RANBP6 TTPAL NUF2 NSD3 TYMS HMCN1 NETO2 GUCY1B1 MCM9 LRP6 KIF2A KPNA3	2.18e-05	819	151	18	gudmap_developingKidney_e15.5_Peripheral blastema_1000
CoexpressionAtlas	Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2	RAD51 INTS6L PHTF2 ADGRG1 NUF2 TYMS MMRN1 HMCN1 NETO2 QSER1 MAD2L1 KIF2C	3.83e-05	410	151	12	GSM791122_500
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	RAB31 MAP2 GART ADGRG1 RAD54L2 AP3B1 CLDN6 PHF21A TWF1 INTS6 CNTNAP5 SLC30A5 HMCN1 TLE5 HADHB RNF128 MRTFA	4.94e-05	791	151	17	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	RAD51 INTS6L PHTF2 ADGRG1 NUF2 TYMS MMRN1 HMCN1 NETO2 QSER1 MAD2L1 KIF2C	5.18e-05	423	151	12	GSM791126_500
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	KPNA4 INTS6L ANK3 STK26 TTPAL CLDN6 GATAD2B CLDN9 SLC15A2 NETO2 MCUR1 ELF2 KIF2A ZNF518B DNMBP CNOT4 VPS13B	5.26e-05	795	151	17	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000	RANBP6 ADD3 NSD3 LIFR VCAN DNMBP	8.51e-05	101	151	6	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	KPNA4 ANK3 STK26 TTPAL GATAD2B ELF2 KIF2A ZNF518B DNMBP CNOT4 VPS13B	8.76e-05	379	151	11	gudmap_developingKidney_e15.5_1000_k3
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STK26 PHTF2 TTPAL GATAD2B RDH11 IGHMBP2 RHEBL1 TMEM209 DKC1	9.40e-09	170	156	9	070d8683d1a5cc7d594ff0453c961a9bf982c2d0
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	RAD51 NUF2 DNAH1 TYMS MCM9 APOL4 PSMC3IP MAD2L1 KIF2C	3.68e-08	199	156	9	c6d59ed26eadd3c41acfe1b4d929270e00ea3e95
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 LRRK2 GRIA2 CNTNAP5 VCAN LRP6 CSMD1 RNF128 SEZ6L	3.68e-08	199	156	9	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Dividing_Macrophages-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	RAD51 NUF2 TYMS NETO2 PSMC3IP NECTIN4 MAD2L1 KIF2C	1.32e-07	166	156	8	ea95b94ccc2ac67df741b30c27f4ae698925875f
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELFE RAD51 GART TYMS PSMC3IP DKC1 MAD2L1 KPNA3	5.07e-07	198	156	8	c78ff8fc71dfcba1ac0c373bc90ea7b87c5699a4
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	CHL1 RPL21 MAP2 GRIA2 NRXN3 NETO2 VCAN PAFAH1B3	5.47e-07	200	156	8	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal\|10w / Sample Type, Dataset, Time_group, and Cell type.	CHL1 EVL ANK3 MAP2 GRIA2 NRXN3 NETO2 PAFAH1B3	5.47e-07	200	156	8	979258173b82f37aeaaedd53b4a527da1dbe1b80
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 MYH6 NRXN3 HMCN1 VCAN PSMC3IP CSMD1	1.93e-06	165	156	7	6d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 MYH6 NRXN3 HMCN1 VCAN PSMC3IP CSMD1	1.93e-06	165	156	7	84f5597b1bb75f42de9a224196bb8ac198bbe3bf
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAD51 CKAP5 NUF2 TYMS VCAN MAD2L1 KIF2C	2.27e-06	169	156	7	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	RAD51 CKAP5 NUF2 TYMS ASL MAD2L1 KIF2C	2.86e-06	175	156	7	0b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TTF1 EMSY NXPE3 CSNK2A2 VCAN PSMC3IP PUS7L	2.97e-06	176	156	7	91ad2c34144f72283ca112fd3b3784f2f6259f65
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VPS13C LRRK2 SH3BP1 MUC19 VCAN C18orf63 CSMD1	4.27e-06	186	156	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Proliferative_AT2_Progenitor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	FSTL4 CLDN6 CLDN9 SLCO4C1 SLC15A2 LGI3 MAD2L1	4.42e-06	187	156	7	e986901f5a1e09cbc9ba37e3c62845ff90ceda95
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAD51 CKAP5 NUF2 TYMS RHEBL1 MAD2L1 KIF2C	4.58e-06	188	156	7	319fbeca200ab998daf49fcaee0bfdb57bf7ee4b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL5 MAB21L3 VCAN DDX25 CSMD1 RNF128 SEZ6L	4.58e-06	188	156	7	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL5 MAB21L3 VCAN DDX25 CSMD1 RNF128 SEZ6L	4.58e-06	188	156	7	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	Entopeduncular-Neuronal\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	CHL1 FSTL4 CNTNAP5 NRXN3 CELSR3 MARCHF4 ATP2B2	5.26e-06	192	156	7	4c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 RAD51 MAP2 GRIA2 TYMS NETO2 PAFAH1B3	5.44e-06	193	156	7	e477f5ddbb9d5878560998250ca0e1a5467953f4
ToppCell	metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ\|metastatic_Lymph_Node / Location, Cell class and cell subclass	RAD51 RNGTT NUF2 ITGAE TYMS MAD2L1 KIF2C	5.82e-06	195	156	7	3c5b7cce4a1c4b28fa3b657cce4148669a59e55e
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-proliferating\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51 TCOF1 NUF2 TYMS PSMC3IP MAD2L1 KIF2C	5.82e-06	195	156	7	b57132802cb977551e214880984f3edcd375474f
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RAD51 CKAP5 NUF2 TYMS PSMC3IP MAD2L1 KIF2C	6.02e-06	196	156	7	9591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAD51 NUF2 TYMS MMRN1 LIFR PTPRB KIF2C	6.02e-06	196	156	7	eb8c9a4a5eb21d43ff7b25deae5896c236f669b9
ToppCell	(3)_MNP-(3)_Macrophage_Dividing\|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)	RAD51 CKAP5 NUF2 TYMS PSMC3IP MAD2L1 KIF2C	6.22e-06	197	156	7	048bc4f8fd5d4f394e2384700640f72042336597
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELFE RAD51 NUF2 TYMS PSMC3IP DKC1 MAD2L1	6.22e-06	197	156	7	d9978aaa476b57144b0561f535ff1dd886c7512b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP2 GRIA2 CNTNAP5 NRXN3 CSMD1 ATP2B2 CAP2	6.43e-06	198	156	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	distal-3-Hematologic-Proliferating_NK/T\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RAD51 NUF2 TYMS PSMC3IP ATP2B2 MAD2L1 KIF2C	6.43e-06	198	156	7	aa23119d73554733981df474648e59918d04edfc
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP2 GRIA2 CNTNAP5 NRXN3 CSMD1 ATP2B2 CAP2	6.43e-06	198	156	7	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP2 NUF2 TYMS PAFAH1B3 PSMC3IP MAD2L1 KIF2C	6.43e-06	198	156	7	06888fe2d42ac66ac12157608becd42764e0d034
ToppCell	AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	LRRK2 LIFR SLCO4C1 RDH11 LRP6 RNF128 AKAP1	6.43e-06	198	156	7	893036558a9ad86b57f9e735df35812e9d18739e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK3 MAP2 GRIA2 NRXN3 CSMD1 ATP2B2 CAP2	6.43e-06	198	156	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 GRIA2 CNTNAP5 VCAN CSMD1 RNF128 SEZ6L	6.65e-06	199	156	7	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 GRIA2 CNTNAP5 VCAN CSMD1 RNF128 SEZ6L	6.65e-06	199	156	7	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 MAP2 LRRK2 CNTNAP5 VCAN CSMD1 SEZ6L	6.87e-06	200	156	7	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 MAP2 LRRK2 CNTNAP5 VCAN CSMD1 SEZ6L	6.87e-06	200	156	7	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	(5)_Epi_dividing\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	RAD51 TCOF1 NUF2 TYMS PAFAH1B3 MAD2L1 KIF2C	6.87e-06	200	156	7	948c55aa1c25f8a69b1bd3ef53fd32aa222f592c
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	RAD51 CKAP5 NUF2 TYMS NETO2 MAD2L1 KIF2C	6.87e-06	200	156	7	548a0f486ab8745da107f2815914dbf873a6e3c8
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NUF2 SVEP1 TYMS GUCY1B1 VCAN MAD2L1 KIF2C	6.87e-06	200	156	7	dd5b753bb1333fa502b9d3a6d65a53a9882b2451
ToppCell	LAM-Myeloid-pMacrophage\|Myeloid / Condition, Lineage and Cell class	RAD51 NUF2 TYMS NETO2 PSMC3IP MAD2L1 KIF2C	6.87e-06	200	156	7	0078d56337d44074326e8ccd1d412d098d86eeab
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 MAP2 LRRK2 CNTNAP5 VCAN CSMD1 SEZ6L	6.87e-06	200	156	7	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	LAM-Myeloid-pMacrophage\|LAM / Condition, Lineage and Cell class	RAD51 NUF2 TYMS NETO2 PSMC3IP MAD2L1 KIF2C	6.87e-06	200	156	7	7e233d037165c9d3607604aaaf0f368e266567d3
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 MAP2 LRRK2 CNTNAP5 VCAN CSMD1 SEZ6L	6.87e-06	200	156	7	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 MAP2 LRRK2 CNTNAP5 VCAN CSMD1 SEZ6L	6.87e-06	200	156	7	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CHL1 MAP2 LRRK2 CNTNAP5 VCAN CSMD1 SEZ6L	6.87e-06	200	156	7	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	COVID-19-kidney-Technical/muscle\|kidney / Disease (COVID-19 only), tissue and cell type	DSG1 FSTL5 CNTNAP5 NRXN3 DDX53 DNAH9	1.39e-05	148	156	6	0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCell	COVID-19_Mild\|World / 5 Neutrophil clusters in COVID-19 patients	ANK3 TUT7 LRRK2 ADGRG1 NSD3 CSMD1	1.61e-05	152	156	6	2ff0980dfd8d430cca14649151d856edef115720
ToppCell	Dividing_Macrophages-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	NUF2 TOP6BL TYMS RHEBL1 MAD2L1 KIF2C	1.61e-05	152	156	6	e39cfc346b35235546b303e7d73e4d9d7120a5fb
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	ADAMTSL1 FSTL5 CNTNAP5 NRXN3 CSMD1 DNAH9	2.08e-05	159	156	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAD51 NUF2 TOP6BL TYMS MAD2L1 KIF2C	2.23e-05	161	156	6	2165897924c790fec43502283f1df221c56c1e9f
ToppCell	LPS-antiTNF-Endothelial-Endothelial-FOXM1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CKAP5 NUF2 TYMS PTPRB MAD2L1 KIF2C	2.39e-05	163	156	6	5285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHL1 ANK3 CLDN6 CLDN9 AATK CSMD1	2.48e-05	164	156	6	3caf4cdaa0164907893fea61e251fd8b5fa926e4
ToppCell	facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS6L TTPAL MMRN1 NPHP3 TLE2 DNMBP	2.74e-05	167	156	6	961e722442d786ab15d1e490941d2be265a9057a
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RBKS GATAD2B LIFR PTPRB SMG7 ARHGEF3	2.74e-05	167	156	6	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INTS6L TTPAL MMRN1 NPHP3 TLE2 DNMBP	2.74e-05	167	156	6	3760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAD51 CKAP5 NUF2 TYMS MAD2L1 KIF2C	2.93e-05	169	156	6	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	droplet-Lung-nan-3m-Lymphocytic-T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51 STK26 NUF2 TYMS MAD2L1 KIF2C	2.93e-05	169	156	6	df2c9c706bfc9db2bc5726602a49f5f5a94e9481
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51 STK26 NUF2 TYMS MAD2L1 KIF2C	2.93e-05	169	156	6	f6a6d2f614d60395ad9b867ff1cf59eba72b04ce
ToppCell	P07-Epithelial-epithelial_progenitor_cell-epi_progenitor\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 ADGRG1 TYMS SLCO4C1 SLC15A2 LGI3	2.93e-05	169	156	6	1a47a4892a5e6a69555f5332308503526e5422a7
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 POLR2A DNAH1 NRXN3 DNAH9 ATP2B2	2.93e-05	169	156	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	NUF2 TYMS SLCO4C1 MGAT5B MAD2L1 KIF2C	3.03e-05	170	156	6	73601c873b177d5d134618d8e228c51381119f7d
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 TOP6BL SH3PXD2B RDH11 TLE2 DKC1	3.03e-05	170	156	6	45de83a2231208b8e1f21061d0b91644b4a3ba93
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ANK3 MAP2 TYMS TMEM209 DNAH9 IPO11	3.13e-05	171	156	6	b113fbebb89056af0b9c775d2fb6552206a80467
ToppCell	TCGA-Brain-Primary_Tumor\|TCGA-Brain / Sample_Type by Project: Shred V9	RAB31 ADGRG1 LIFR SLC15A2 HADHB CNOT4	3.34e-05	173	156	6	f6ba22661e67c17d49d1058d4170ba8f36bf47f0
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAD51 NUF2 TYMS PTPRB PSMC3IP MAD2L1	3.45e-05	174	156	6	c988471207ba06195bc3e41056435e8c31c20bbe
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 RAD51 MAP2 TYMS LIFR KIF2C	3.56e-05	175	156	6	cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9
ToppCell	10x_5'_v1-Neoplastic-Stem-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 RAD51 MAP2 TYMS LIFR KIF2C	3.56e-05	175	156	6	a8400e7e47379901dcab5f2e364c3ff17765b4b9
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHL1 ANK3 INTS6 AATK CELSR3 ZFYVE26	3.56e-05	175	156	6	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 RAD51 MAP2 TYMS LIFR KIF2C	3.56e-05	175	156	6	8a3abf40146ae3459d97cdf865c1c8f6b92ac639
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 RAD51 MAP2 TYMS LIFR KIF2C	3.56e-05	175	156	6	378d2b79edac91fc74eee0fb42bb29dd9b07c36f
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial-AT2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ANK3 LRRK2 ADGRG1 SLCO4C1 SLC15A2 LGI3	3.68e-05	176	156	6	ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a
ToppCell	droplet-Spleen-nan-21m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51 NUF2 TWF1 NETO2 MAD2L1 KIF2C	4.04e-05	179	156	6	dabecd283c1f0f71a66b804c99be8bd48ea36e35
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NUF2 TYMS RHEBL1 PAFAH1B3 MAD2L1 KIF2C	4.17e-05	180	156	6	42f48e646fc6e72ad3cce72409ace3a0b64020a2
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAD51 CKAP5 NUF2 TYMS MAD2L1 KIF2C	4.17e-05	180	156	6	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTSL1 MMRN1 NRXN3 PTPRB HMCN1 IPO11	4.30e-05	181	156	6	cef034030e6b029a49ae56be37ea1fac1a5c350e
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	STK26 NUF2 TYMS PSMC3IP MAD2L1 KIF2C	4.30e-05	181	156	6	e4dbc09f0210de465d8347969b301c22463a2b7d
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51 NUF2 CELSR3 NETO2 MAD2L1 KIF2C	4.43e-05	182	156	6	bc6a120dedc813c58baac1428c39851a07b71ba7
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T\|Liver / Manually curated celltypes from each tissue	RAD51 NUF2 TYMS C18orf63 MAD2L1 KIF2C	4.43e-05	182	156	6	81557cdc88777f3bd4e1dd18a760b08fc29122ef
ToppCell	NS-control-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RPL21 RAD51 NUF2 TYMS MAD2L1 KIF2C	4.43e-05	182	156	6	f623c47e7806181d09f126066a952162ce49a306
ToppCell	wk_15-18-Epithelial-PNS-SST+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CHL1 FSTL5 CNTNAP5 CELSR3 ATP2B2 SEZ6L	4.43e-05	182	156	6	a7e77aaaddabf78c7784f72b3431703fc5ee4a8c
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51 NUF2 CELSR3 NETO2 MAD2L1 KIF2C	4.43e-05	182	156	6	0fc45214f0b0766f69be6eff69cc4bec574023aa
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	RAB31 LRRK2 VCAN CSMD1 DNMBP DHX34	4.71e-05	184	156	6	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 TBC1D25 MMRN1 AATK CSMD1 RNF128	4.71e-05	184	156	6	e33bb572af9dfd11127105f1ac99bc958a7cafbb
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FSTL5 CNTNAP5 CELSR3 DDX25 MARCHF4 ATP2B2	4.86e-05	185	156	6	edb114487206e4e8df4c7878285df40f49b7fd64
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 RAD51 TYMS PSMC3IP MAD2L1 KIF2C	5.00e-05	186	156	6	4fe8e0bf74c7dbf73634cafdacad89020d2634d0
ToppCell	Dividing_Macrophages-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	RAD51 CKAP5 NUF2 TYMS MAD2L1 KIF2C	5.00e-05	186	156	6	0067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCell	Epithelial-C_(AT2)\|World / shred on cell class and cell subclass (v4)	ANK3 LRRK2 ADGRG1 SLCO4C1 SLC15A2 LGI3	5.00e-05	186	156	6	b7b1763fc52b4485d843a4a6727055e6c95ebad3
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTSL1 NUF2 TYMS MMRN1 MAD2L1 KIF2C	5.00e-05	186	156	6	5d527050cd554cc46c6d8dcb7981900725d79fc6
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTSL1 NUF2 TYMS MMRN1 MAD2L1 KIF2C	5.00e-05	186	156	6	ee1c3e2adfa2900542200a218746b576c7ed10dc
ToppCell	facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 AATK GUCY1B1 CSMD1 CAP2	5.31e-05	188	156	6	794fc1d9a726945c42f7eac221eed938309b47a9
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ANK3 NRXN3 UBR5 VCAN MGAT5B SEZ6L	5.31e-05	188	156	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADAMTSL1 ANK3 FSTL5 CLDN6 NRXN3 NECTIN4	5.47e-05	189	156	6	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	ADAMTSL1 MMRN1 NRXN3 PTPRB HMCN1 VCAN	5.47e-05	189	156	6	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAD51 CKAP5 NUF2 TYMS MAD2L1 KIF2C	5.47e-05	189	156	6	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C NXPE3 PSMC3IP DKC1 PUS7L IPO11	5.63e-05	190	156	6	52c59001a079c76249abbaa3141e9e661b83d9a0
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAD51 CKAP5 NUF2 TYMS MAD2L1 KIF2C	5.63e-05	190	156	6	b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CHL1 HIP1 GRIA2 VCAN RNF128 SEZ6L	5.63e-05	190	156	6	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EVL ANK3 ADD3 NSD3 TLE5 KIF2A	5.63e-05	190	156	6	f6616b3fe7f4962249503c96c06926240066d861
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	RAD51 ADGRG1 NUF2 TYMS PTPRB KIF2C	5.63e-05	190	156	6	451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	RAD51 NUF2 TYMS NETO2 MAD2L1 KIF2C	5.80e-05	191	156	6	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAD51 NUF2 TYMS NETO2 MAD2L1 KIF2C	5.80e-05	191	156	6	d6e158f16a183c9203c057192342e9b83e79bc89
Drug	cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A	RAD51 DSG3 PHF21A SMG7 SLC15A2 RDH11 UBR5 PAFAH1B3 TMEM209 PSMC3IP	7.78e-07	196	151	10	379_UP
Drug	CNI-H0294	KPNA4 TYMS KPNA3	2.83e-06	5	151	3	CID000073088
Drug	Sulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	HIP1 SVEP1 SLC30A5 SMG7 TMEM209 LRP6 KIF2A DHX34 CNOT4	6.13e-06	194	151	9	5732_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A	TCTN3 GART TTPAL TMEM209 LRP6 DNMBP DHX34 HCFC1 GABPB1	6.66e-06	196	151	9	5833_DN
Drug	Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A	HIP1 RAB31 PHTF2 ATP9B AP3B1 NSD3 SLC30A5 NFRKB KIF2A	6.66e-06	196	151	9	2113_DN
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A	RAD51 RNGTT TOP6BL EMSY SMG7 TLE2 KIF2A DHX34 CNOT4	6.66e-06	196	151	9	2229_DN
Drug	Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; PC3; HT_HG-U133A	RAB31 RNGTT NXPE3 AATK NRXN3 TMEM209 LRP6 AKAP1 HCFC1	6.93e-06	197	151	9	3995_DN
Drug	Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; HL60; HT_HG-U133A	NR2C1 RNGTT PHTF2 RBKS EMSY DHX34 HCFC1 CNOT4 GABPB1	7.22e-06	198	151	9	3038_DN
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A	RAD51 PHTF2 TOP6BL SLC30A5 SMG7 GUCY1B1 VCAN KIF2A CNOT4	7.22e-06	198	151	9	4661_DN
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	RNGTT PHTF2 AP3B1 EMSY SVEP1 NSD3 VCAN QSER1 MRTFA	7.52e-06	199	151	9	4316_DN
Drug	Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	TOP6BL SVEP1 PTPRB SLC30A5 CELSR3 IGHMBP2 CEP250 CD40 MRTFA	7.84e-06	200	151	9	4082_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	RBKS ATP9B NSD3 SLC30A5 SMG7 VCAN TMEM209 GABPB1	4.72e-05	194	151	8	4281_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A	TBC1D5 AP3B1 SLC30A5 VCAN TMEM209 KIF2A AKAP1 VPS13B	4.72e-05	194	151	8	1856_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	RAD51 PHTF2 EDC4 RAD54L2 SLC30A5 GUCY1B1 TLE2 DHX34	4.72e-05	194	151	8	4325_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	RNGTT ANK3 TOP6BL CLDN9 NSD3 VCAN CEP250 CD40	4.90e-05	195	151	8	7539_DN
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A	HIP1 PHTF2 NXPE3 SMG7 SLC15A2 ZFYVE26 DHX34 CNOT4	4.90e-05	195	151	8	3135_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A	RNGTT TBC1D5 TTPAL RAD54L2 PSMC3IP LRP6 DHX34 HCFC1	4.90e-05	195	151	8	2122_DN
Drug	Esculetin [305-01-1]; Down 200; 22.4uM; HL60; HT_HG-U133A	NR2C1 ATP9B SMG7 VCAN CD40 DHX34 ENO3 MRTFA	4.90e-05	195	151	8	3120_DN
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A	RAD51 GART NSD3 IGHMBP2 TMEM209 ARHGEF3 CNOT4 MRTFA	5.08e-05	196	151	8	2382_DN
Drug	AG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A	RNGTT GART TTPAL NXPE3 VCAN AKAP1 DHX34 GABPB1	5.08e-05	196	151	8	6582_DN
Drug	Scoulerine [6451-73-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	RNGTT PHTF2 AP3B1 SLC30A5 SMG7 GUCY1B1 QSER1 GABPB1	5.08e-05	196	151	8	5111_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	TBC1D5 SVEP1 SLC30A5 SMG7 CD40 DHX34 HCFC1 MRTFA	5.08e-05	196	151	8	2086_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	HIP1 RAB31 ATP9B SLC30A5 SMG7 TMEM209 AKAP1 PUS7L	5.08e-05	196	151	8	7298_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; HL60; HT_HG-U133A	PHTF2 IGHMBP2 VCAN TMEM209 DHX34 HCFC1 CNOT4 MRTFA	5.08e-05	196	151	8	2373_DN
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A	RNGTT GART PHTF2 SLC30A5 CEP250 LRP6 QSER1 CNOT4	5.26e-05	197	151	8	5087_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	HIP1 ATP9B EMSY TMEM209 ZFYVE26 QSER1 CNOT4 MRTFA	5.26e-05	197	151	8	3247_DN
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; MCF7; HT_HG-U133A	TBC1D5 ADGRG1 SLC30A5 TLE2 DHX34 HCFC1 MRTFA GABPB1	5.26e-05	197	151	8	4754_DN
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	NR2C1 AP3B1 NSD3 AATK NRXN3 SMG7 CD40 DHX34	5.26e-05	197	151	8	6867_DN
Drug	Milrinone [78415-72-2]; Up 200; 19uM; PC3; HT_HG-U133A	CCDC170 RNGTT TBC1D5 TTF1 NRXN3 LRP6 DHX34 CNOT4	5.46e-05	198	151	8	5856_UP
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	HIP1 POLR2A TGM4 PTPRB SLC30A5 TLE2 ATP2B2 HCFC1	5.46e-05	198	151	8	4278_UP
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	RAD51 PHTF2 SMG7 CEP250 LRP6 KIF2A CNOT4 MRTFA	5.46e-05	198	151	8	3018_DN
Drug	rotenone; Up 200; 1uM; PC3; HT_HG-U133A	HIP1 RNGTT RBKS IGHMBP2 CD40 TMEM209 ATP2B2 MRTFA	5.46e-05	198	151	8	5948_UP
Drug	Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; HL60; HT_HG-U133A	RAD51 NR2C1 RNGTT PHTF2 SMG7 CEP250 AKAP1 CNOT4	5.46e-05	198	151	8	3033_DN
Drug	minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA	NR2C1 TCOF1 POLR2A RBKS ADD3 SLC15A2 NFRKB KIF2A	5.46e-05	198	151	8	1135_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	NR2C1 POLR2A CELSR3 KIF2A ARHGEF3 AKAP1 HCFC1 PUS7L	5.46e-05	198	151	8	5325_DN
Drug	rotenone; Up 200; 1uM; PC3; HT_HG-U133A	MAP2 ATP9B SMG7 CELSR3 TLE2 QSER1 ENO3 MRTFA	5.65e-05	199	151	8	5920_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	TCOF1 POLR2A RBKS AP3B1 SLC15A2 PSMC3IP HCFC1 PUS7L	5.65e-05	199	151	8	6923_DN
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A	RAB31 ANK3 RAD54L2 IGHMBP2 NFRKB TMEM209 KIF2A DHX34	5.65e-05	199	151	8	5804_DN
Drug	Monobenzone [103-16-2]; Up 200; 20uM; PC3; HT_HG-U133A	RAD51 SVEP1 TGM4 TLE2 DHX34 ATP2B2 HCFC1 CNOT4	5.65e-05	199	151	8	6713_UP
Drug	Phytoestrogens	RAD51 NUF2 TYMS CSNK2A2 KIF2C	8.33e-05	67	151	5	ctd:D048789
Drug	ethyl methanesulfonate	RAD51 POLR2A GART TYMS UBR5 ASL	9.84e-05	111	151	6	CID000006113
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	RAB31 TBC1D5 TTF1 ADD3 RYBP AKAP1 CAP2	1.84e-04	177	151	7	985_DN
Drug	AC1L9FQV	EVL RNGTT POLR2A ELF2 ENO3	2.17e-04	82	151	5	CID000444118
Drug	celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA	RNGTT POLR2A GART PHTF2 CELSR3 SLC15A2 AKAP1	2.57e-04	187	151	7	887_DN
Drug	pM15	GART VCAN	2.60e-04	4	151	2	CID000485469
Drug	Pemetrexed	GART TYMS	2.60e-04	4	151	2	DB00642
Drug	5,8-dideazafolic acid	GART TYMS	2.60e-04	4	151	2	CID003080619
Drug	AC1L7GLZ	DSG3 CD40	2.60e-04	4	151	2	CID000360406
Drug	MS-275; Down 200; 10uM; PC3; HT_HG-U133A	NR2C2 TTF1 EMSY SMG7 ZFYVE26 GABPB1 KIF2C	2.74e-04	189	151	7	7074_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA	RAD51 NR2C1 TCOF1 POLR2A TUT7 PHTF2 AKAP1	2.83e-04	190	151	7	1044_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	ANK3 PHTF2 SLC30A5 SMG7 TMEM209 CNOT4 MRTFA	2.83e-04	190	151	7	4322_DN
Drug	trichostatin A; Up 200; 0.1uM; PC3; HG-U133A	RAB31 RNGTT MAP2 LIFR SLC30A5 GUCY1B1 LRP6	2.92e-04	191	151	7	448_UP
Drug	Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	NR2C1 RNGTT PHTF2 EMSY CD40 DHX34 CNOT4	2.92e-04	191	151	7	2227_DN
Drug	Iodipamide [606-17-7]; Down 200; 3.6uM; PC3; HT_HG-U133A	NR2C1 PHTF2 RBKS LIFR SMG7 TMEM209 QSER1	2.92e-04	191	151	7	5085_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	TCOF1 RAD54L2 VCAN TMEM209 DKC1 AKAP1 HCFC1	3.02e-04	192	151	7	1153_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A	PHTF2 RAD54L2 AP3B1 TLE2 IGHMBP2 HCFC1 CNOT4	3.02e-04	192	151	7	3929_DN
Drug	SC 19220; Down 200; 10uM; PC3; HT_HG-U133A	RAB31 VPS13C GART RBKS EMSY SMG7 GABPB1	3.02e-04	192	151	7	7065_DN
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A	GART PHTF2 RAD54L2 SMG7 CEP250 DHX34 GABPB1	3.02e-04	192	151	7	6659_DN
Drug	Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A	RAD51 ANK3 ATP9B NSD3 DNMBP DHX34 VPS13B	3.11e-04	193	151	7	3139_DN
Drug	Isocarboxazid [59-63-2]; Up 200; 17.2uM; PC3; HT_HG-U133A	HIP1 EMSY CLDN9 NRXN3 PTPRB SLC15A2 HCFC1	3.11e-04	193	151	7	3684_UP
Drug	Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; HL60; HG-U133A	RNGTT SMG7 UBR5 ASL PAFAH1B3 NFRKB AKAP1	3.11e-04	193	151	7	1550_DN
Drug	Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; HL60; HG-U133A	SMG7 NETO2 VCAN DKC1 AKAP1 MRTFA KPNA3	3.11e-04	193	151	7	1773_DN
Drug	Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A	EMSY SVEP1 SMG7 CELSR3 GUCY1B1 DHX34 MRTFA	3.11e-04	193	151	7	4067_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A	HIP1 NRXN3 PTPRB SMG7 LRP6 HCFC1 MRTFA	3.11e-04	193	151	7	4240_DN
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; PC3; HT_HG-U133A	TCTN3 GART PHTF2 AP3B1 GUCY1B1 TMEM209 KIF2A	3.11e-04	193	151	7	7375_DN
Drug	Prednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	RNGTT EMSY NSD3 VCAN LRP6 QSER1 VPS13B	3.11e-04	193	151	7	5119_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	GART PHTF2 EMSY SLC30A5 VCAN MCM9 DKC1	3.11e-04	193	151	7	2949_DN
Drug	Primidone [125-33-7]; Down 200; 18.4uM; PC3; HT_HG-U133A	TBC1D5 PHTF2 TLE5 NFRKB LRP6 DHX34 CNOT4	3.21e-04	194	151	7	6723_DN
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A	RNGTT CLDN9 NXPE3 PTPRB SLC30A5 NFRKB PUS7L	3.21e-04	194	151	7	4599_UP
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	NR2C1 CLDN9 SMG7 TLE5 AKAP1 DHX34 HCFC1	3.21e-04	194	151	7	6995_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A	RAD51 NSD3 LIFR VCAN DHX34 ATP2B2 MRTFA	3.21e-04	194	151	7	4546_UP
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	ANK3 MAP2 SMG7 VCAN TMEM209 LRP6 HCFC1	3.31e-04	195	151	7	7058_DN
Drug	2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A	ANK3 PTPRB GUCY1B1 TLE2 CEP250 CD40 DHX34	3.31e-04	195	151	7	1214_UP
Drug	Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	RAD54L2 EMSY SVEP1 NXPE3 SLC30A5 TMEM209 HCFC1	3.31e-04	195	151	7	3478_UP
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	HIP1 ANK3 PHF21A SLC15A2 LRP6 KIF2A CNOT4	3.31e-04	195	151	7	1650_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	TBC1D5 PHTF2 SMG7 TLE2 VCAN NFRKB HCFC1	3.31e-04	195	151	7	4644_DN
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	RAB31 RNGTT IRF2 RBKS NXPE3 SLC30A5 KIF2A	3.31e-04	195	151	7	2125_DN
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; PC3; HT_HG-U133A	RAB31 NSD3 PTPRB VCAN CEP250 CD40 CNOT4	3.31e-04	195	151	7	4234_DN
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RAD51 ADGRG1 ATP9B RAD54L2 SMG7 VPS13B MRTFA	3.31e-04	195	151	7	4358_DN
Drug	Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; PC3; HT_HG-U133A	RAB31 RNGTT RBKS SVEP1 SLC30A5 CD40 LRP6	3.31e-04	195	151	7	7393_UP
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	POLR2A EMSY SMG7 IGHMBP2 MCM9 CD40 LRP6	3.31e-04	195	151	7	2064_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A	NR2C1 AATK NRXN3 VCAN LRP6 MRTFA PUS7L	3.31e-04	195	151	7	4433_DN
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	CCDC170 TBC1D5 GART NSD3 CELSR3 DNMBP HCFC1	3.31e-04	195	151	7	1045_UP
Drug	Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ANK3 TOP6BL CELSR3 SLC15A2 LRP6 QSER1 DHX34	3.31e-04	195	151	7	1704_DN
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; HL60; HT_HG-U133A	POLR2A EMSY NSD3 SMG7 ASL ARHGEF3 CNOT4	3.31e-04	195	151	7	1336_DN
Drug	Testosterone propionate [57-85-2]; Down 200; 11.6uM; PC3; HT_HG-U133A	RAB31 NRXN3 PTPRB SMG7 GUCY1B1 TLE2 HCFC1	3.31e-04	195	151	7	4676_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; PC3; HT_HG-U133A	HIP1 AP3B1 SVEP1 NSD3 GUCY1B1 IGHMBP2 MRTFA	3.42e-04	196	151	7	5749_DN
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	HIP1 RAD54L2 EMSY NSD3 CELSR3 TMEM209 KIF2A	3.42e-04	196	151	7	3233_DN
Drug	Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A	GART PHTF2 GUCY1B1 TLE2 LRP6 KIF2A DNMBP	3.42e-04	196	151	7	1821_DN
Drug	Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RAD51 RNGTT PHTF2 ADGRG1 IRF2 SMG7 CEP250	3.42e-04	196	151	7	5418_DN
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	TOP6BL AP3B1 NFRKB TMEM209 LRP6 HCFC1 MRTFA	3.42e-04	196	151	7	7353_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A	CHL1 DSG3 VCAN CD40 DNAH9 ATP2B2 SEZ6L	3.42e-04	196	151	7	2270_UP
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; HL60; HT_HG-U133A	RAD51 TBC1D5 GART PHTF2 AP3B1 KIF2A CNOT4	3.42e-04	196	151	7	2951_DN
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	RNGTT GART PHTF2 SLC30A5 ZFYVE26 QSER1 CNOT4	3.42e-04	196	151	7	2844_DN
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A	ATP9B SLC30A5 SMG7 CEP250 LRP6 DHX34 VPS13B	3.42e-04	196	151	7	3095_DN
Drug	6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A	RNGTT TCOF1 SMG7 IGHMBP2 CEP250 AKAP1 DHX34	3.42e-04	196	151	7	4833_UP
Drug	Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A	TTPAL NSD3 SLC30A5 VCAN TMEM209 LRP6 MRTFA	3.42e-04	196	151	7	2406_DN
Drug	Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	NR2C1 RNGTT TOP6BL AP3B1 SMG7 TMEM209 QSER1	3.42e-04	196	151	7	5386_DN
Drug	ICI 182,780; Down 200; 1uM; ssMCF7; HG-U133A	GART EDC4 AATK UBR5 DKC1 LRP6 PUS7L	3.42e-04	196	151	7	523_DN
Drug	PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A	RNGTT ADGRG1 SVEP1 VCAN NFRKB TMEM209 DHX34	3.42e-04	196	151	7	5979_UP
Disease	pneumonia, COVID-19	ADAMTSL1 MAP2 TBC1D5 STK26 CSMD1 VPS13B	2.43e-05	113	149	6	EFO_0003106, MONDO_0100096
Disease	Cohen syndrome (implicated_via_orthology)	VPS13C VPS13B	7.57e-05	3	149	2	DOID:0111590 (implicated_via_orthology)
Disease	dyskeratosis congenita (is_implicated_in)	TYMS DKC1	7.57e-05	3	149	2	DOID:2729 (is_implicated_in)
Disease	glucosamine 6-phosphate N-acetyltransferase measurement	PSMC6 ARHGEF3	1.51e-04	4	149	2	EFO_0801626
Disease	spermidine measurement	CNTNAP5 ARHGEF3	2.51e-04	5	149	2	EFO_0021802
Disease	ras-related protein Rab-22A measurement	RAB31 ARHGEF3	2.51e-04	5	149	2	EFO_0802991
Disease	BRICHOS domain-containing protein 5 measurement	SH3BP1 ARHGEF3	3.75e-04	6	149	2	EFO_0801430
Disease	heparan sulfate glucosamine 3-O-sulfotransferase 3A1 measurement	ADD3 ARHGEF3	3.75e-04	6	149	2	EFO_0801671
Disease	HOMA-IR	RCOR1 MCM9 CSMD1	6.16e-04	33	149	3	EFO_0004501
Disease	bipolar disorder	KPNA4 ANK3 MAP2 FSTL5 RBKS TOP6BL SVEP1 ADD3 RHEBL1 ATP2B2	7.30e-04	577	149	10	MONDO_0004985
Disease	nasal disorder	RANBP6 EMSY NRXN3	7.34e-04	35	149	3	MONDO_0002436
Disease	sporadic amyotrophic lateral sclerosis	ADAMTSL1 ANK3 FSTL4 ZFYVE26 ATP2B2	7.41e-04	140	149	5	EFO_0001357
Disease	hepatocyte growth factor-like protein measurement	RAD54L2 DNAH1 CELSR3	9.35e-04	38	149	3	EFO_0008154
Disease	postburn hypertrophic scarring severity measurement	DSG1 CSMD1	1.11e-03	10	149	2	EFO_0007747
Disease	Liver carcinoma	IRF2 NUF2 TYMS LIFR CELSR3 CSMD1 MAD2L1 CAP2 KIF2C	1.14e-03	507	149	9	C2239176
Disease	Fetal Alcohol Spectrum Disorders	CHL1 ANK3	1.90e-03	13	149	2	C2985290
Disease	neutrophil collagenase measurement	NELFE DNMBP	2.90e-03	16	149	2	EFO_0008248
Disease	Colorectal Carcinoma	CHL1 EVL MAP2 TCOF1 FSTL5 OBSCN TYMS LIFR IQUB GABPB1	3.09e-03	702	149	10	C0009402
Disease	Malignant neoplasm of breast	RAD51 EVL OBSCN EMSY TYMS ASL CD40 NFYC ZFYVE26 ADGRF4 HADHB DNAH9 VPS13B	3.20e-03	1074	149	13	C0006142
Disease	Antihistamine use measurement	RANBP6 EMSY	3.28e-03	17	149	2	EFO_0009943
Disease	rhinitis	RANBP6 EMSY	3.28e-03	17	149	2	EFO_0008521
Disease	phosphatidylcholine 40:6 measurement	CSMD1 DNAH9	3.28e-03	17	149	2	EFO_0010389
Disease	Fetal Alcohol Syndrome	CHL1 ANK3	3.28e-03	17	149	2	C0015923
Disease	insulin resistance	AP3B1 CSMD1 SEZ6L	3.34e-03	59	149	3	EFO_0002614
Disease	asthma, Eczema, allergic rhinitis	EMSY RYBP RCOR1 SLC15A2	3.36e-03	121	149	4	EFO_0005854, HP_0000964, MONDO_0004979
Disease	pursuit maintenance gain measurement	LIFR CSNK2A2 CSMD1 CAP2	3.56e-03	123	149	4	EFO_0008433
Disease	age at onset, Parkinson disease	DSG3 QSER1	3.67e-03	18	149	2	EFO_0004847, MONDO_0005180
Disease	Tourette syndrome, schizophrenia	TBC1D5 NSD3	3.67e-03	18	149	2	EFO_0004895, MONDO_0005090
Disease	late-onset Alzheimers disease	ANK3 ADAM18 CKAP5 PSMC6 HMCN1 CSNK2A2	3.76e-03	292	149	6	EFO_1001870
Disease	Adenocarcinoma of lung (disorder)	GART TTF1 TYMS AATK SLC15A2	4.01e-03	206	149	5	C0152013
Disease	Grand Mal Status Epilepticus	ANK3 GRIA2 CD40	4.77e-03	67	149	3	C0311335
Disease	Status Epilepticus, Subclinical	ANK3 GRIA2 CD40	4.77e-03	67	149	3	C0751522
Disease	Simple Partial Status Epilepticus	ANK3 GRIA2 CD40	4.77e-03	67	149	3	C0751524
Disease	Non-Convulsive Status Epilepticus	ANK3 GRIA2 CD40	4.77e-03	67	149	3	C0751523
Disease	Petit mal status	ANK3 GRIA2 CD40	4.77e-03	67	149	3	C0270823
Disease	Complex Partial Status Epilepticus	ANK3 GRIA2 CD40	4.77e-03	67	149	3	C0393734
Disease	Eczema, allergic rhinitis	RANBP6 EMSY RYBP RCOR1 SLC15A2	4.80e-03	215	149	5	EFO_0005854, HP_0000964
Disease	response to paliperidone, schizophrenia symptom severity measurement	EVL ADAMTSL1 FSTL5 HMCN1 CSMD1	4.90e-03	216	149	5	EFO_0007925, EFO_0007927
Disease	Status Epilepticus	ANK3 GRIA2 CD40	4.98e-03	68	149	3	C0038220

Protein segments in the cluster

Peptide	Gene	Start	Entry
GVTVVLVDKENINNT	TTF1	101	Q15361
DGITVEVIVVNQVNA	AKAP1	706	Q92667
INIIQGIVAEINTKT	ARHGEF3	291	Q9NR81
KIIVTEGSGIQIQVI	CSMD1	1831	Q96PZ7
GVVEDKQTQESVTQI	VCAN	476	P13611
ASNLVKVNIIGEVVD	ADD3	186	Q9UEY8
TSGVLVVLDVVNLVQ	APOL4	296	Q9BPW4
AVTQKIVQVIGLVNT	ADAM18	206	Q9Y3Q7
SIQVVGVVEALIQSA	SH3BP1	451	Q9Y3L3
AVNLIVVLVVAVNTQ	ADGRF4	571	Q8IZF3
TNAVLAVKEINVNIN	DNMBP	951	Q6XZF7
LQRAGVLVQKVVTTT	RAD54L2	1061	Q9Y4B4
LQSQKGVQGIIVVNT	DYNLRB1	11	Q9NP97
GIDVKQVTIVVNFDL	DDX25	401	Q9UHL0
IIFGTVIQEVKTSNV	HADHB	101	P55084
IEQEQKFTVVRAGQV	ATP2B2	186	Q01814
VIFQKVVNVANVGAV	AP3B1	1021	O00203
TQGIFTKVIQEIARV	RHEBL1	156	Q8TAI7
QAISDVIGNKSVVQV	RCOR1	406	Q9UKL0
TEQQTGQKIQIVTAL	NR2C1	21	P13056
VTDQQTGQKIQIVTA	NR2C2	26	P49116
GAIVVETSAKNAINI	RAB31	141	Q13636
KEESVVGSVTQLNQQ	QSER1	631	Q2KHR3
VAVVITNQVVAQVDG	RAD51	261	Q06609
LAQVQRIVKGEVSVA	EDC4	1216	Q6P2E9
ESLVQKVQSGVVINF	INTS6L	221	Q5JSJ4
ESLVQKVQSGVVINF	INTS6	221	Q9UL03
KNEVDSTVNIIVVGQ	IRF2	166	P14316
EQVTGGIKAIVQLVN	PAFAH1B3	111	Q15102
IIVNNEGQNIIVIVA	RBKS	111	Q9H477
QAIATLIEKQAQIVV	CCDC43	101	Q96MW1
VVDKNTGDINITAIV	DSG3	101	P32926
VTVAQQAQVVTTVVG	HCFC1	641	P51610
SVVLLNITVGKEETQ	PTPRB	416	P23467
SVKDSQVVQVVLDGL	KPNA3	421	O00505
ATQQAEIIVSALVKI	MCUR1	181	Q96AQ8
VQKLVVVISNIESGE	MAD2L1	81	Q13257
VVVKTLEQLAQQGKI	PSMC3IP	46	Q9P2W1
TAAVIQNVTGQNIIK	NFRKB	906	Q6P4R8
QNVTGQNIIKQVAIT	NFRKB	911	Q6P4R8
VTQVTTQPKLGEVQQ	RNGTT	241	O60942
NGTQVESVQLKVNIA	NELFE	316	P18615
VQQVPTIIKQSKVQV	CHL1	31	O00533
IIQKVNESVVSIAAQ	MMRN1	426	Q13201
AVLQVATGVISTLQI	ASL	341	P04424
QVKSSDIQVGDLIIV	ATP9B	226	O43861
TTEGQVQVLKVVENA	IPO11	741	Q9UI26
IQQVVSSGGQQVITI	GABPB1	261	Q06547
IKTVQGVNVTINCQV	ADAMTSL1	1296	Q8N6G6
IVEVINSQDIQIQVM	CAP2	391	P40123
LARVQNITQVGSVTK	ITGAE	266	P38570
IQAIAQNVSDIAVKV	MGAT5B	121	Q3V5L5
VNDIVDQVITIGKHV	GRIA2	216	P42262
VTTINQEIQKIKLGI	NUF2	391	Q9BZD4
QNIVLQDGKVTAVKS	MUC19	1341	Q7Z5P9
TFRVVGVKLQDQQVV	EVL	46	Q9UI08
QALGVITEKETQVIL	ERAL1	151	O75616
AIQVITNKVVLKVGV	HHLA2	126	Q9UM44
VDTKVVTQVINGAKN	NRXN3	971	Q9Y4C0
AEAVQIVAKNTVTLV	PHF21A	191	Q96BD5
NKTESVQNVVVSGLL	LRP6	81	O75581
VQEGKQIETLVQILE	LRRK2	26	Q5S007
GLQDIVIGIIKTVAQ	GUCY1B1	141	Q02153
VIGIIKTVAQQIHGT	GUCY1B1	146	Q02153
VVQKTPVVQNAASIV	GATAD2B	196	Q8WXI9
VINQKTGEINITSIV	DSG1	101	Q02413
VTMQVGEGQQVQIVQ	NFYC	191	Q13952
RQQISQAVEEVQKVV	MAB21L3	21	Q8N8X9
IVDVQSQKVVQAVST	FSTL5	526	Q8N475
VATNIAGNVTQAVKL	HMCN1	1151	Q96RW7
VTAKNTVVRGLENVE	OBSCN	4336	Q5VST9
VLEDGKQQVQVVGLQ	KIF2A	386	O00139
EVLSVVAQQITTIQK	DNAH1	1641	Q9P2D7
GQQVIRSVNLLVVKV	CKAP5	1661	Q14008
VVDIQAQKVLQSIGV	FSTL4	526	Q6MZW2
SVIEVTKGQLEVQIQ	CEP250	781	Q9BV73
TKGQLEVQIQTVTQA	CEP250	786	Q9BV73
EVQIQTVTQAKEVIQ	CEP250	791	Q9BV73
QVLGEKVLGIVVQNT	ADGRG1	306	Q9Y653
EVVKVLVTNGANVNA	ANK3	121	Q12955
EAINITNNERVVVKI	CSNK2A2	56	P19784
LGQKISTVAVQSVNA	ELF2	401	Q15723
QAISLTVIEKVQVAA	MARCHF4	226	Q9P2E8
VSQIITVTVQTGLDQ	IQUB	221	Q8NA54
VAVNTVKQNIIVTTE	DDX53	436	Q86TM3
FVKGQIVILEETINV	CCDC170	206	Q8IYT3
LLKVNQIGSVTESIQ	ENO3	341	P13929
QTVVQVLAVKTTQQL	EMSY	1041	Q7Z589
EQIESINVGGTKLVI	SDR42E2	116	A6NKP2
VLSVVAVQVKSIQDA	DNAH9	1931	Q9NYC9
VKENSIVGSVVAQIT	CELSR3	1076	Q9NYQ7
GIEVNQEIVVITTKG	DKC1	326	O60832
ILQTLKEHQVVVVAG	DHX34	171	Q14147
VKVTVVGNENNSLLI	SLC15A2	426	Q16348
VLEDGKQQVQVVGLQ	KIF2C	421	Q99661
GKQSAVVLNINVTET	C18orf63	136	Q68DL7
SVLIERVGKQVNFTV	CNTNAP5	271	Q8WYK1
VQEQRNVTIKGVENS	LIFR	476	P42702
EIKIQEQVQRLSVGS	MCM9	201	Q9NXL9
QTKINEAIVAVQAII	RTRAF	216	Q9Y224
VAKEIQTTTGNQQVL	RDH11	81	Q8TC12
NITQVVILSAVSGVI	PHTF2	756	Q8N3S3
TVLANQTLLVEGQVI	SEZ6L	346	Q9BYH1
TQVGRTLSKVQQVLS	TBC1D25	171	Q3MII6
VQGSIQFTVDKVLEQ	TOP6BL	366	Q8N6T0
LNEAQVQASVVKVLT	TCOF1	1306	Q13428
AQVVVKELQASASVQ	AATK	151	Q6ZMQ8
KTVVVIRTANAQELG	NXPE3	476	Q969Y0
GSIIIVIDSIDQVQQ	NPHP3	616	Q7Z494
VIEIDEQGQLVNKTI	PUS7L	36	Q9H0K6
NVVGIQVTETAKVNI	SPATA31A6	326	Q5VVP1
GIDNRTQQVVAIKII	STK26	41	Q9P289
NVVGIQVTETAKVNI	SPATA31A7	326	Q8IWB4
AQQLAVTVGNVTVII	RYBP	156	Q8N488
EKLQETGKQNVAVQV	SMG7	601	Q92540
TVSINKAINTQEVAV	HIP1	41	O00291
QSIQRGIQVTMVIEV	RNF128	181	Q8TEB7
TVLVVEGIAVAQKTQ	NETO2	16	Q8NC67
LNKTSQIQGQVSEVT	TGM4	526	P49221
GKTVTVKEDQVLQQN	MYH6	66	P13533
NQLVLKELTTEVGVV	SVEP1	2331	Q4LDE5
IISIIAEGKINETIN	RANBP6	1046	O60518
VESSLKEAIIVGQVN	MRTFA	91	Q969V6
RVKDLQVVSSNVGVE	OXCT2	81	Q9BYC2
KVTAFIGNSIVVAQV	CLDN6	31	P56747
KVTAFIGNSIVVAQV	CLDN9	31	O95484
ASVRVVQKNLVFVVG	CNOT4	101	O95628
QQQVLGAIERAKQVT	TLE5	101	Q08117
KLIQSEETQVNGIVI	TTPAL	171	Q9BTX7
NVVGIQVTETAKVNI	SPATA31A3	326	Q5VYP0
NAVGIQVTETAKVNI	SPATA31A1	326	Q5TZJ5
NVVGIQVTETAKVNI	SPATA31A5	326	Q5VU36
VTQGIVVNGLVNISI	SLCO4C1	116	Q6ZQN7
VVNGLVNISISTVEK	SLCO4C1	121	Q6ZQN7
TTTVVEIILQAVKQG	IGHMBP2	221	P38935
ISLSVGQVVDIIEKN	SH3PXD2B	171	A1X283
GSKINISQVIAVVGQ	POLR2A	776	P24928
ISQVIAVVGQQNVEG	POLR2A	781	P24928
VKLTVVVNNIAVAEQ	TRAF7	166	Q6Q0C0
QGVDQLQRVIDTIKT	TYMS	156	P04818
NVTQHAVGIVVNKQV	RPL21	66	P46778
VLVQIDATEGNKVIT	VPS13C	2526	Q709C8
GAVLVVSKEQTEQIL	GART	736	P22102
VIGKVQIQVADLSEI	NSD3	1081	Q9BZ95
QVVTAEAVAVLKGEQ	MAP2	96	P11137
QQTLLGLKTAVVQTT	TMEM209	101	Q96SK2
VQQGIQIIQIEDKTT	VPS13B	3096	Q7Z7G8
IVQQVTGILKDAGVN	SLC30A5	706	Q8TAD4
QSVGQIVGEVLKQLT	PSMC6	51	P62333
LGPTIAIVTKVNQIQ	TBC1D5	291	Q92609
IQKVSVSLGQTNLTV	TCTN3	336	Q6NUS6
QINAVGIAIDKVVQE	TUT7	291	Q5VYS8
VKKVVVVEQNGSFQV	ZNF740	81	Q8NDX6
QQVLQAVERAKQVTV	TLE2	101	Q04725
VAVQTLQQLLVGQEI	ZFYVE26	1696	Q68DK2
DLVVQQAGTNKTDVV	CD40	171	P25942
QIKINEVQTDVGVDT	TWF1	156	Q12792
SQAQVVLQGKSRSVI	UBR5	191	O95071
QLIDVKVVNGTQQLV	ZNF518B	346	Q9C0D4
TVKDAQVVQVVLDGL	KPNA4	421	O00629
RTQKQFVAQGEVTQV	LGI3	406	Q8N145
KQVDLVSASVVVVGV	NECTIN4	341	Q96NY8